[144] Enova International, Inc. SEC Filing

Rhea-AI Filing Summary

Enova International, Inc. (ENVA) has filed a Form 144 notifying the SEC of a proposed sale of 2,000 common shares through Merrill Lynch on the NYSE, tentatively scheduled for 06/20/2025. The aggregate market value is listed at $196,760, implying an estimated price of about $98.38 per share. With 25,366,770 shares outstanding, the transaction represents less than 0.01 % of total shares.

The filing names David Fisher as the seller. Over the past three months he has already disposed of 9,000 shares (5,000 on 03/25/2025, 2,000 on 04/28/2025 and 2,000 on 05/22/2025) for cumulative gross proceeds of $888,721.90. If the newly noticed sale is executed, total dispositions would rise to 11,000 shares. The shares being sold were originally acquired via stock-option exercises in February 2019.

Form 144 filings merely signal an intent and do not obligate the insider to complete the sale. The document contains no additional financial metrics or strategic commentary.

Insights

Securities Analyst

TL;DR – Planned 2,000-share sale (<0.01% float) is immaterial and unlikely to affect ENVA valuation.

The filing discloses a small disposition relative to Enova’s 25.4 million shares outstanding. At roughly $196.8 K, the sale amounts to less than one-day average trading volume for the stock and should not impact liquidity or pricing. Although the seller has reduced holdings by 11,000 shares in three months, the total remains negligible. Investors typically watch insider trends, yet the modest scale and routine use of Rule 144 suggest limited signalling value. No operational or financial data accompanies the notice, so the core investment thesis remains unchanged.

Corporate Governance Expert

TL;DR – Routine Rule 144 notice; insider selling trend continues but lacks material governance concern.

Form 144 compliance indicates proper disclosure of intended insider transactions. The aggregate 11,000-share reduction over three months is typical for option-related liquidity events and stays well below thresholds that normally trigger heightened board or market scrutiny. Absence of a stated relationship in the form slightly limits context, yet the consistent reporting cadence suggests adherence to internal trading policies. From a governance standpoint, no red flags emerge beyond the standard caveat that persistent insider selling can influence sentiment if coupled with other adverse signals, which are not evident here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 110 N Wacker Dr Ste 1900 Chicago IL 60606	2000	196760.00	25366770	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2019	Stock Options	Enova International			2000	02/19/2019	Stock Option

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Fisher 175 West Jackson Blvd Suite 600 Chicago IL 60604	Common	03/25/2025	5000	508548.91
David Fisher 175 West Jackson Blvd Suite 600 Chicago IL 60604	Common	04/28/2025	2000	197218.02
David Fisher 175 W Jackson Blvd. Suite 600 Chicago IL 60604	Common	05/22/2025	2000	182954.97

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Enova (ENVA) shares are covered in the latest Form 144?

The filing covers 2,000 common shares.

When is the approximate sale date for the 2,000 ENVA shares?

The seller indicates an approximate sale date of 06/20/2025.

What portion of Enova’s outstanding shares does the planned sale represent?

It represents less than 0.01 % of the 25,366,770 shares outstanding.

Who is the seller named in the Form 144 filing?

The seller is listed as David Fisher.

How many shares has the same seller disposed of during the past three months?

He previously sold 9,000 shares across three transactions.

What is the aggregate market value of the planned 2,000-share sale?

The filing cites an aggregate market value of $196,760.